Zynex, Inc, an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.
Health Technology Insights: Providers Express Frustration with Prior Authorization, Favor Real‑Time Tech Fix
On June 30, 2025, the Company announced the Board’s appointment of Steven Dyson as the incoming CEO. Since that time, Mr. Dyson and Thomas Sandgaard, the Chairman of the Board, have been actively working with the Board of Directors to round out the executive team and several critical leadership roles within the company. Today the Company is announcing the addition of the following individuals, all of whom have started with the company as of August 18, 2025.
- Vikram Bajaj, Chief Financial Officer
- John T. Bibb, Chief Legal Officer
- Ajay Gopal, EVP of Sales
- Agnes Powell, VP of Billing
Vikram Bajaj joins as Chief Financial Officer with over 20 years of leadership experience in finance, M&A, and strategy within the med-tech sector. Previously, he served as CFO of Vyaire Medical, CFO of Kepro, and as Head of Corporate Development at Kinetic Concepts (KCI). Earlier in his career, Vikram was an investment banker at J.P. Morgan in New York, advising healthcare companies on M&A as well as equity and debt capital markets. He began his career in public accounting with Arthur Andersen and is a Chartered Accountant.
Health Technology Insights: Lyra Health Study Finds AI Can Reduce Mental Health Care Costs Without Sacrificing Outcomes
John Bibb, our new Chief Legal Officer, is a seasoned executive leader with over 20 years’ experience in legal, compliance and HR roles in the med-tech sector, including roles with Kinetic Concepts, Inc., LifeCell, and most recently Vyaire Medical. He has served as an executive leader with companies in private and public environments through M&A, capital markets, complex litigation, government disputes, compliance remediation, and intellectual property exploitation. In his new role, Mr. Bibb will be responsible for the Company’s Legal, HR, Compliance and Communications functions.
Ajay Gopal, our new EVP of Sales, is a proven commercial leader in the healthcare and medical device sectors, with prior successful roles at KCI, Danaher, and Healthium Medtech. He is known for delivering transformative growth, high‑integrity team leadership, and improving access to impactful products that improve lives.
Agnes Powell, our new VP of Billing, brings 20 years of experience in leading revenue cycle operations, compliance, and managed care contracting across diverse healthcare settings. She has a proven track record of managing billing processes with a strong commitment to integrity and regulatory compliance. Her background spans hospitals, private practices, and billing companies. Agnes has held key roles at HealthOne, Centura Health, and Toxicology Associates, contributing in various capacities.
Steven Dyson’s executive leadership team will consist of Messrs. Bajaj and Bibb, together with Anna Lucsok, the Company’s COO, and Donald Gregg, President of Zynex Monitoring Solutions. “I am very pleased that we have been able to move quickly to fill critical roles at the Company as we begin to create a new future for all Zynex stakeholders,” said Mr. Dyson. “We have a lot to do to improve business performance at the Company over the coming quarters. I believe we now have the right team in place to deliver excellent results in the future, while renewing our commitment to the highest integrity in our business practices and fulfilling our mission to improve the quality of life for patients suffering from debilitating pain and illness.”
Thomas Sandgaard, founder and Chairman of the Board, added “The Board is delighted to welcome Steven Dyson as CEO, together with his new executive team to Zynex. We are confident that this group of experienced, proven leaders will take Zynex to new levels of success. The Board and I are looking forward to supporting Steven and the rest of the management team in Zynex’s next chapter.”
Health Technology Insights: ZAP Surgical Treats 5,000 Patients with ZAP-X Radiosurgery
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
